Barriers and facilitators for preventing adverse drug reactions of long latency: a qualitative study.
Caplan L, Haverhals LM. Barriers and facilitators for preventing adverse drug reactions of long latency: a qualitative study. Int J Risk Saf Med. 2012; 24(2):81-94.